Issue 2-3/2011
Special Issue on Immunology at Pitt: Bench to Bedside in 2011
Content (24 Articles)
Transcriptional and epigenetic regulation of B cell development
Patricia Santos, Fortuna Arumemi, Kyung Soo Park, Lisa Borghesi, Christine Milcarek
Regulation of NF-κB induction by TCR/CD28
Jing Cheng, Angela Montecalvo, Lawrence P. Kane
Macrophage responses to bacterial toxins: a balance between activation and suppression
Peter A. Keyel, Michelle E. Heid, Russell D. Salter
Dendritic cells and the maintenance of self-tolerance
Penelope A. Morel, Michael S. Turner
Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity
Valentina Di Caro, Antonella D’Anneo, Brett Phillips, Carl Engman, Jo Harnaha, Massimo Trucco, Nick Giannoukakis
Lung myeloid-derived suppressor cells and regulation of inflammation
Prabir Ray, Meenakshi Arora, Stephanie L. Poe, Anuradha Ray
Role of TNF superfamily ligands in innate immunity
Nikola L. Vujanovic
Pneumocystis infection and the pathogenesis of chronic obstructive pulmonary disease
Karen A. Norris, Alison Morris
IL-17 signaling in host defense against Candida albicans
Sarah L. Gaffen, Nydiaris Hernández-Santos, Alanna C. Peterson
Role of neurokinin-1 receptor in the initiation and maintenance of skin chronic inflammatory diseases
Sherrie J. Divito, Adrian E. Morelli, Adriana T. Larregina
Latent tuberculosis: what the host “sees”?
Hannah P. Gideon, JoAnne L. Flynn
A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice
Ming S. Lin, Hubert M. Tse, Meghan M. Delmastro, Suzanne Bertera, Caterina T. Wong, Robert Lakomy, Jing He, Martha M. Sklavos, Gina M. Coudriet, Massimo Pietropaolo, Massimo M. Trucco, Jon D. Piganelli
Hepatic antigen-presenting cells and regulation of liver transplant outcome
Angus W. Thomson, David A. Geller, Chandrashekhar Gandhi, Noriko Murase, A. Jake Demetris, Donna Beer-Stolz
Dissecting the role of dendritic cells in simian immunodeficiency virus infection and AIDS
Elizabeth R. Wonderlich, Muhamuda Kader, Viskam Wijewardana, Simon M. Barratt-Boyes
Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
Pawel Kalinski, Howard Edington, Herbert J. Zeh, Hideho Okada, Lisa H. Butterfield, John M. Kirkwood, David L. Bartlett
Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity
Steve C. Lee, Raghvendra M. Srivastava, Andrés López-Albaitero, Soldano Ferrone, Robert L. Ferris
A role for the heat shock protein–CD91 axis in the initiation of immune responses to tumors
Sudesh Pawaria, Michelle Nicole Messmer, Yu Jerry Zhou, Robert Julian Binder
Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas
Olivera J. Finn, Kira R. Gantt, Andrew J. Lepisto, Sharmila Pejawar-Gaddy, Jia Xue, Pamela L. Beatty
T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract
Binfeng Lu, Lujun Chen, Lin Liu, Yibei Zhu, Changping Wu, Jingting Jiang, Xueguang Zhang
Targeting myeloid regulatory cells in cancer by chemotherapeutic agents
Hiam Naiditch, Michael R. Shurin, Galina V. Shurin
Immunotherapeutic potential of oncolytic vaccinia virus
Steve H. Thorne
The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells
Ling Yu, Elvira Favoino, Yangyang Wang, Yang Ma, Xiaojuan Deng, Xinhui Wang